Open to all in the veterinary profession, the event offers up to ten hours of CPD, and covers a range of topics such as orthopaedics, ECC, medicine, wellbeing, and education.
There will also be practical sessions to attend on both days on transfusions, CPR, and physio.
Speakers include:
There's a commercial exhibition, and social events including the Ceilidh at the annual BSAVA PetSavers Gala Dinner on Friday evening.
Prices start at £85 +VAT for a day pass, with early bird rates offered to both BSAVA members and non-members until 27th July.
Additional discounts are available when sending the whole practice team.
https://www.bsavaevents.com/bsavaalba23/en/page/home
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.
New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
All donations of unwanted clothes, books or bric-a-brac are sent for sale in one of the charity's 55 charity shops around the UK.
Working in partnership with National Veterinary Services (NVS), empty donation bags are given to veterinary practices to fill with goods for NVS to collect and deliver to the charity. The partnership with NVS began in 2011 and so far over 60,000 bags have been collected, with an estimated value of over £1m.
Mark Corbett, Head of Retail at Blue Cross said: "We are extremely grateful to NVS, the vet practices taking part in the scheme and their clients. Although the donated items may be unwanted possessions to some, each bag generates about £20 of income for us. This means the scheme has so far provided an incredible amount of income towards helping the pets in our care.
Blue Cross receives no government funding, so relies on public donations to continue its vital work.
Veterinary practices that receive their stock and drugs from NVS but are not yet part of The Blue Cross donation scheme can sign up now by contacting their NVS representative or email trading@bluecross.org.uk.
The project was 'highly commended' at the RCVS Knowledge 2024 awards.
The CVS clinical improvement project found that a major barrier to conducting ultrasound scans was a lack of confidence - both in using equipment and interpreting images.
A recent Canadian industry study has also reviewed barriers, citing a lack of equipment, training and skills as root causes1.
The ultrasound project aimed to review practice equipment, improve clinician case identification, increase clinical skills and confidence, and recommend ultrasound in all appropriate cases.
The company put together resources for vets and nurses designed to help improve ultrasound scan rates, including clinical guidelines, webinars for how to approach cases, and machine guides.
CVS then held training sessions which for vets focussed on case identification and improving diagnostic skills, and for vet nurses looked at how to use ultrasound equipment and conduct scans.
An audit of each participating practices’ ultrasound scan rates was conducted at the start of the project. Results were then shared with each practice every month.
Twelve months after launch, data shows that the number of ultrasound scans has increased by 3,675.
Anecdotal evidence has also shown that colleague confidence and practice team culture has improved as a result of the project.
Dr Victoria Woods, Regional Clinical Lead at CVS responsible for the ultrasound clinical improvement project, said: “It’s fantastic to see the benefits increased ultrasonography is already bringing to our practices on this project – especially as a result of upskilling our nurses.
"I am certain that this will help contribute towards them providing some of the best clinical diagnosis and care in our profession.”
Following the success of the project in its first year, the project is now being developed to focus on echocardiograph and is being undertaken in 52 CVS primary care practices in year two.
Reference
Epiphen, Vétoquinol's canine anti-epileptic drug, has been re-launched with new packaging and a useful dosing syringe.
"Some of our customers reported that they were having difficulty administering the drops accurately," explains Slavica Sobot, Product Manager. "So with this in mind, we have introduced a new plug-on syringe which will make it even easier for pet owners to dose accurately. The syringe will prevent the risk of inaccurate dosing through ‘flooding' from the dropper."
For more information, please call the Vétoquinol help line on 0800 169 8197 or contact your Vétoquinol representative.
William McEwan BSc MRes PhD, now working at the MRC-Laboratory of Molecular Biology in Cambridge, has been awarded the ABCD and Merial Young Scientist of the Year Award 2010 for his work on the replication and cross-species transmission of feline immunodeficiency virus infection in domestic cats and lions, and the restriction factors in these species in particular.
Dr McEwan said: "Understanding the means by which host species are able to prevent viral replication gives us insight to the mechanisms of infection and may allow us to engineer therapy based on similar mechanisms or by enhancing immune responses."
The award was presented by Professor Marian C. Horzinek, Chair of the European Advisory Board on Cat Diseases (ABCD) and of the award jury. He said: "William McEwan presented a very original, high quality paper. His research has indicated the ability of hosts to potently restrict retroviral replication - given sufficient evolutionary time. It has also highlighted felids as a taxon that is potentially highly prone to cross-species transmission of immunodeficiency viruses".
The ABCD and Merial Young Scientist Award, created in 2008 and worth 1000 €, is funded by Merial and is presented to a young scientist in veterinary or biomedical science, who has made an original contribution in the field of feline infectious diseases and/or immunology. Applicants should have published their findings in a journal listed in PubMed or Web of Science or have had them accepted by another recognised assessing body.
Candidates should be based in Europe, have completed a veterinary or biomedical curriculum, and be under 35 years of age at the time of application. Applications for the 2011 award are now being invited (deadline 15 January 2011). For more information, visit: www.abcd-vets.org
Dechra Veterinary Products has published a new series of video presentations about the diagnosis and treatment of canine hypoadrenocorticism to help veterinary surgeons who are prescribing Zycortal for the condition.
The six videos, which were recorded by Dechra's technical team, range in length from 10 minutes to 37 minutes.
Episode one describes the pathophysiology of Addison’s disease, different types of Addison’s disease and helps veterinary surgeons recognise the common clinical presentations of chronic hypoadrenocorticism.
Episode two examines the similarities in clinical presentation between hypoadrenocorticism and other disease processes.
The third episode looks at the changes commonly seen in the haematology, biochemistry and urinalysis of Addison’s patients. This section also covers how to perform and interpret hormone testing with the knowledge of the common causes of false positive results.
The fourth looks at a clinical presentation of an acute Addisonian crisis and best practice for emergency treatment of these patients, as well as the transfer of an acute patient onto maintenance treatment with Zycortal.
The final two films explore the treatment and monitoring of a patient on Zycortal and how to switch existing Addisonian patients from fludrocortisone acetate to Zycortal. It also documents the help which is available for those more complex cases.
Dechra Brand Manager Craig Sankey said: "These short films are an important support tool for any veterinary professional who is treating patients with hypoadrenocorticism or who may be presented with cases in their practice.
"Addison’s disease can be very hard to diagnose as it mimics so many other illnesses and we hope these presentations will give insights into a complex disease. The introduction of Zycortal has been a vital development in the treatment of the disease and we hope the new resources will be beneficial to veterinary professionals."
The presentations complement resources that Dechra has already produced for dog owners, including a website -www.myaddisonsdog.co.uk - which provides information and resources to help dog owners understand the condition and monitor their pet's progress.
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
Speakers at the event include Toby Trimble, founder of Trimble Productions and a Specialist in Veterinary Anaesthesia and Analgesia, who will be advising on public speaking, Jonny Hughes, Diagnostic Imaging Specialist at Davies Veterinary Specialists, who will lead an interactive session reviewing radiographs from four real-life cases, and Emily Thomas, Specialist in Emergency and Critical Care at Dick White Referrals, who will appraise recent cases she has seen with her intern team.
Career experiences and advice will be shared by a live panel of current rotating interns.
In another session, residency programme directors from Linnaeus hospitals will offer their tips for successfully applying to a residency post.
Attendees will also be able to watch live sessions with interns and specialists performing diagnostics and procedures, including a laparoscopic spay at Eastcott and an echocardiographic exam at Anderson Moores.
Natasha Hetzel, Internship and Residency Manager at Linnaeus (pictured right), said: “This is the perfect opportunity to hear from peers who have completed a rotating internship, and watch live sessions showcasing the teaching that interns receive. Attendees will also receive support from experts on the internship application process, including a chance to book 1.1 sessions with internship directors for further advice.
“The event will also consider routes into residencies and becoming a specialist, as these are popular career routes for interns. However, an internship is also an excellent way to develop the skills and knowledge for a career in primary care.”
Attendees unable to join on the day can still register to watch the recorded sessions.
To register, visit: https://www.linnaeusgroup.co.uk/careers/internships/internships-explained.
Pfizer VPS has launched a 'Pre-Sale Scab Treatment Certificate' so that sheep treated for sheep scab and protected against re-infestation beyond their autumn sale date can be formally certified as such.
A choice of two moxidectin-based treatments are eligible for use, one with 28 days and the other 60 days licensed persistency against the scab mite.
Pfizer VPS vet David Bartram explained that following treatment, the sale date must fall within the persistency window: "The idea is that farmers present their certificate at markets on sale day, then auctioneers announce the scab-protected status during their sales patter. Whether this adds to the sale price will be interesting to find out, but it's sure to be seen as a valuable attribute by buyers who won't need to treat for scab when they arrive home."
Details of the certification process are available from SQPs at animal medicine suppliers. The two eligible treatments are CYDECTIN 1% LA and CYDECTIN 2% LA for sheep.
I'm delighted to welcome Celia Marr from Rossdales and Edd Knowles from Bell Equine, who have kindly agreed to be our contributing experts. They'll drop in from time to time to add anything helpful they can to the forum discussions.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
All members of the site with an interest in equine medicine are now invited to press the join button on the left hand side of the group home page (when viewed on tablet or bigger). You may also wish to select the option to receive a daily or weekly digest of new content by email, which you can cancel at any time.
Equine is the third special interest group launched on VetSurgeon.org. The other two are Small Animal Medicine and Small Animal Dentistry.
Mike, an RCVS Queen’s Medal winner, will be in conversation with Catheryn Partington BVSc CertAVP(VC) MSc MRCVS, Jose Matos DVM DipECVIM (Cardiology) MRCVS European and RCVS Recognised Specialist in Small Animal Cardiology (canine and feline cardiology) and Paul Freeman MA, VetMB, Cert SAO, Dip ECVN, MRCVS (European and RCVS Specialist in Veterinary Neurology) (canine and feline neurology).
During the event, they will be explaining how Improve's new Academy Series can help vet professionals meet their annual CPD targets, learn through self-assessment and reflective study, and bring them to the forefront of medicine in several specialist areas.
Heber Alves, CEO of Improve International, said: “Here at Improve International, we are proud to be providing CPD training alongside the historic and prestigious University of Cambridge for our first Academy Series.
"We are excited to be working with many of its pioneering specialists at the Department of Veterinary Medicine and, as a former vet myself, I look forward to hearing how my fellow veterinarians handled the most difficult challenges of their careers.”
www.improveinternational.com
Following a nationwide search to find the UK’s top veterinary professionals for 2008 and judged by an independent panel of experts, Petplan has announced the final short-list for the Petplan Veterinary Awards to be presented on 3rd April in Birmingham.
Those short-listed for the four categories of the Petplan Veterinary Awards acknowledging achievement in the veterinary world include:
Vet of the Year Brian Faulkner of the Melton Veterinary Surgery, Woodbridge Linda Glenn of the Glenn Veterinary Clinic, Bangor Girish Thakral of the Blacks Veterinary Group, Dudley
Vet Nurse of the Year Louisa Baker of the Priors Leaze Veterinary Centre, Chichester Alison Devonshire of the Orwell Veterinary Group, Ipswich Mark Vince of The Animal Clinic, Catford
Vet Receptionist of the Year Margaret Coupe of the Hedge End Veterinary Health Centre, Southampton Margaret Gait of Cinque Ports Veterinary Associates, Lydd Sandie Rule of the Eastcott Veterinary Clinic, Swindon
Vet Practice of the Year Battle Flatts Veterinary Clinic, York Orwell Veterinary Group, Ipswich Woodlands Veterinary Clinic, Cheltenham
The RCVS has announced a number of senior staff changes.
Gordon Hockey has been ratified by Council as Head of Legal Services and Registrar. This is a new role created when the post of Registrar and Secretary was split into two: Chief Executive and Secretary; and Head of Legal Services and Registrar.
Gordon, who was previously Assistant Registrar/Head of Professional Conduct, and then Acting Registrar, will have oversight responsibility for registration and professional conduct.
At the same time, Eleanor Ferguson, formerly Acting Head of Professional Conduct, has been confirmed in the position.
The post of Head of Registration has been made redundant, with a new role of Customer Experience Manager created to ensure that the customer (public and profession) journey improves across the organisation. This position will also report into Gordon Hockey.
There have been other changes on the Senior Team at the College. The post of Head of Corporate Services that had been vacant since the departure of Richard Holford last December will not be filled, and Head of Finance Corrie McCann has been promoted to the new role of Head of Operations, which will incorporate finance, corporate services (IT, mailing, reception) and facilities.
Two other posts have been made redundant: Special Projects Manager and RCVS Charitable Trust Director. A new post of Executive Director for the Trust will be developed, with a view to taking the Trust through a full strategic review.
Chief Executive Nick Stace said: "I believe that an engaged and well-purposed team of staff, with a focus on customer service and driving improvements, lies at the heart of any successful organisation. These changes will enable the College to move into the next stage of its development towards becoming a first-rate regulator."
The changes will mean that the Senior Team is reduced from 11 people to seven, being the Chief Executive plus Heads of Legal Services, Operations, Human Resources, Education, Veterinary Nursing and Communications.
Dr Vlad Butnaru faced two charges, the first of which was that in May 2021, he had signed a passport and/or passport application for a horse and electronically signed a declaration stating that he “had read the above microchip, which had previously been implanted for the animal” when, in fact, the microchip had not been inserted into any horse and he had not read it.
The second charge was that, in relation to the matters set out in the first charge, Dr Butnaru’s signed declaration was false, and that he had acted dishonestly and misleadingly, he risked undermining procedures designed to promote animal welfare, and failed to take sufficient steps to ensure that the microchip number recorded for the horse was accurate.
Dr Butnaru admitted the first charge on all counts, and that the declaration he had signed was false.
He also admitted that his conduct was misleading and that he had failed to take sufficient steps to ensure that the microchip number recorded for the horse was accurate.
However, he denied that his conduct had been dishonest and that he had risked undermining a procedure designed to promote animal welfare.
In its decision, the committee noted that Dr Butnaru kept introducing new versions of what happened for the first time at the hearing and changed his account as he went along, as well as being evasive when answering questions.
The Committee therefore felt that Dr Butnaru could not be considered to be a reliable witness, and whilst it did not know the true reason why he was prepared to sign a false declaration on a passport application, it was satisfied that he'd made a false declaration dishonestly.
The Committee also found that Dr Butnaru had failed to take sufficient steps to ensure that the microchip number recorded for the horse was accurate as, if the passport had been issued on a false premise because of misleading information provided by Dr Butnaru, then it could not function as it was meant to which, in the Committee’s view, clearly risked undermining procedures designed to protect animal welfare.
The Committee found that Dr Butnaru had breached the parts 6.2 and 6.5 of the Code of Professional Conduct, as well as Principle 1 of the 10 Principles of Certification, namely that ‘a veterinarian should certify only those matters which: a) are within his or her own knowledge; b) can be ascertained by him or her personally; c) are the subject of supporting evidence from an authorised veterinarian who has personal knowledge of the matters in question; or d) are the subject of checks carried out by an Officially Authorised Person (OAP).’
The Committee found there were no mitigating factors.
Aggravating factors, on the other hand, were that Dr Butnaru had participated in premeditated misconduct, made financial gain from his actions as he was paid to make the false declaration, abused his professional position, and showed blatant or wilful disregard of the Horse Passport System and of the role of the RCVS and the systems that regulate the veterinary profession.
The Committee found that all proven charges amounted to Disgraceful Conduct in a Professional Respect.
On considering the sanction, the Committee once again considered the aggravating factors, as well as additional mitigating factors in that Dr Butnaru had no previous disciplinary history, showed limited insight by admitting to some of the charges, showed expressions of remorse, and was provided with a positive testimonial.
Paul Morris, chairing the Committee and speaking on its behalf, said: “The Committee was cognisant of the importance of a veterinary surgeon’s signature on any document.
"This should have been obvious to any veterinary surgeon, but particularly someone of Dr Butnaru’s 11 years’ experience (at the time of signing).
"The Committee was well aware of the impact and ramifications for Dr Butnaru of any decision to remove him from the Register, but had to weigh his interests with those of the public.
“In doing so it took account of the context and circumstances of the case, all matters of personal mitigation, Dr Butnaru’s previous unblemished record and the need to act proportionately.
"However, the Committee was of the view that the need to uphold proper standards of conduct within the veterinary profession, together with the public interest in maintaining confidence in the profession of veterinary surgeons and protecting the welfare of animals, meant that a period of suspension would not be sufficient.
"His actions were fundamentally incompatible with remaining on the Register and thus the only appropriate and proportionate sanction in all the circumstances of this case was that of removal from the Register.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The lower age limit for student veterinary nurses - previously set at 17 - has been removed by the Royal College of Veterinary Surgeons, in order to comply with age discrimination legislation.
The entry requirements remain unchanged: five GSCEs at grade C or higher, or five Scottish Standards at grades one to three (including English Language, Maths and a Science subject).
Candidates must also have a place with an RCVS-approved Training Practice or on a recognised veterinary nursing degree course.
Libby Earle, Head of Veterinary Nursing said: "We hope that the removal of this age barrier will be seen as a positive step that will serve to improve access to training. Practices remain free to recruit as they see fit to meet the particular demands of their business."
New veterinary nursing careers leaflets have been produced to reflect the change and are available from vetnursing@rcvs.org.uk / 020 7202 0711, or to download from RCVSonline: www.rcvs.org.uk/publications
The awards, which were first launched last year, are open to UK practices, branch surgeries or other organisations who employ veterinary surgeons or nurses. They were created to highlight wellbeing in the veterinary profession and celebrate workplaces where:
• health and happiness are valued;• there are systems and initiatives that motivate;• staff are engaged;• communication is positive;• there is commitment to being a better place to work.
The prize for each category includes two registrations and banquet tickets for SPVS/VPMA Congress 2018 where the winners will be announced to the media and will be available for interview.
Practices that are thinking about applying can now access a free five-minute Wellbeing Checklist that can help provide examples of some simple activities that can improve the health and wellbeing of the veterinary team.
Nick Stuart from SPVS said: "Taking five minutes to fill out the Wellbeing Checklist is a great way to get a sense of how your practice is doing, and to identify ways in which you could improve. Practices are often doing a lot more than they realise and the Checklist shows how even such small steps as a having a fruit bowl in the staff room, or having a five-minute huddle at the start of the day, can make a huge difference."
Lizzie Lockett, MMI Director, said: "Having a supportive and constructive culture is key not just for the welfare of the staff, but for the animals they take care of. It allows all members of the team to feel comfortable coming forward with questions, clarifications, or even mistakes, and can ultimately lead to safer and more consistent care for patients."
Entries can be made now via the website www.vetwellbeingawards.org.uk, where the Wellbeing Checklist is also available.
The closing date for entries is Friday 15 December 2017. You can follow the awards on twitter @vetwellbeing and Facebook /vetwellbeingawards/.
The ‘Midgeater' device introduced by Calor in 2003 to combat biting midges causing irritation to humans, has now been successfully tested by leading scientists as a monitoring device in the fight against bluetongue.
Leading midge scientist Dr Alison Blackwell, who is the Managing Director of University of Edinburgh based Advanced Pest Solutions, presented her company's findings in her keynote speech to the Royal Entomological Society in Belfast on November 19th.
The current method of trapping midges when monitoring the deadly bluetongue virus is a light trap, but Alison and her team have established that a modified Midgeater can be more effective in catching the main midge species that carry the virus.
Alison said: "During trials this year, we found that Calor fuelled Midgeater traps modified with a simple ‘black' light source and fitted with an octenol / ammonia bait, proved to be far more effective at catching the main species of midge known to carry the bluetongue virus than the light traps which are currently used to monitor midge populations in relation to the disease".
Farmers throughout the UK recently commenced a vaccination programme to protect their animals from the only strain of the bluetongue virus that has so far been encountered in the UK, serotype 8, but there is still a real need to carefully monitor biting midge populations, as other strains of the virus are approaching our shores.
Alison added: "In the last few weeks serotype 1 and serotype 6 have been found in Northern Europe and there are currently no vaccines available in the UK for these types of the bluetongue virus, so it is important that we remain vigilant and monitor midges throughout the UK".
Advanced Pest Solutions have tested their modified Midgeater traps in England and Wales. The English, project which was carried out at a specialist bull breeding facility, also included the use of the Barrfly air curtain, from fellow Scottish business Innovent.
Alison explained: "Innovent's air curtain is designed to prevent midges passing through it into sensitive areas. The insects simply aren't strong enough to fly through the air currents it produces.
"The air curtain, combined with the Calor supplied traps and APS's consultancy and analysis creates a comprehensive ‘assess, protect and stop', midge management system that businesses can use to reduce the exposure to the risks of midge borne diseases."
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."
“Assessment of the clinical usefulness of ultrasound-guided cytological specimens obtained from gastrointestinal lesions in dogs and cats” retrospectively reviewed GI cytological samples obtained by ultrasound-guided FNCB of 25 dogs and 19 cats from a single institution between February 2014 to August 2016.
The aim of the study was to assess factors that may influence the clinical usefulness of submitted cytological samples collected from gastrointestinal lesions by ultrasound-guided percutaneous FNCB. Ultrasound-guided FNCB included a combination of FNI (non-aspiration) and FNA techniques, as the specific technique could not be determined retrospectively.
Clinical records were evaluated to obtain historical data, clinical findings, diagnostic results and patient outcomes. Clinically useful samples were defined as smears with sufficient cell yield and preservation to allow at least a tentative cytological diagnosis of the lesion character or pathological process.
Factors that may have influenced the retrieval of a clinically useful sample were assessed and included lesion location, sonographic lesion thickness, loss of or alteration to intestinal layer conspicuity on ultrasound, and the number of slides submitted to the cytologists. The thickness of lesions was further categorised as either a mass (≥20 mm thickness) or a thickening (<20mm).
Fort Dodge (makers of Equest equine worming brands, and Deosect), is launching a new Equine Parasites Reference Manual.
The manual, which is supported by AHDA, AMTRA and BEVA, is billed as 'an objective and comprehensive reference guide covering endoparasites and ectoparasites and their control, as well as offering prescribing tips, a glossary of terms and reference sources'.
Fort Dodge has produced the manual to provide an ‘all in one’ guide to support veterinary professionals and Suitably Qualified People (SQPs) involved in prescribing equine parasite treatments. It brings together, in an A5 spiral bound booklet, all the information they may need on the full range of licensed veterinary medicines to control equine parasites of concern in the UK. It will be launched at BETA (17-19 February at the NEC).
For further information about the manual (or to get a copy), please contact Fort Dodge on 01489 781711.
The Alliance to Save Our Antibiotics is urging the Prime Minister to make the announcement on antimicrobial resistance he promised the House of Commons during Prime Minister's Questions on Wednesday 7th May 2014.
In a reply to a question from Zac Goldsmith MP, David Cameron acknowledged that the problem of antibiotic resistance could have 'unbelievably bad consequences' leading to quite minor ailments not being properly treatable by antibiotics. The Alliance is urging the government to take urgent action to reduce antibiotic use in both medicine and farming.
The issue was further highlighted at this year's World Health Assembly (WHA) Conference when attendees confirmed that a catastrophic post-antibiotic age - in which minor, common infections could again become killers - is a real possibility unless urgent action is taken.
At the conference, the Netherlands' Minister of Health, Edith Schippers said: "People are getting seriously ill and are dying as a result of skin infections and diarrhoea. Common surgeries like knee replacement will become potential killers because of secondary infections that are untreatable. This is a global problem on a par with, if not more serious than, nuclear security, international terrorism and climate change."'
In a letter to David Cameron on 13th May 2014, the Alliance to Save Our Antibiotics said: "It simply does not make sense to be feeding nearly half of all the antibiotics used in this country to farm animals, just so that they can be kept in high numbers indoors, often in conditions which carry with them the risk of high levels of disease."
The Alliance says the measures the Prime Minister is due to announce must include the urgent phase-out of the routine preventative use of antibiotics in farming.
Alison Craig, Campaign Manager for the Alliance to Save Our Antibiotics said: "Our near European neighbour the Netherlands has phased out routine preventative use of antibiotics in farming by government taking strong and decisive action and industry taking voluntary measures - so why can't we do the same in the UK?"
In 2007 the Netherlands was one of the world's heaviest users of antibiotics in food animals. In 2009 the government decided to decrease farm use of antibiotics by 50%. This was achieved by 2013.
Alison continued: "It is alarming that, in this country, we don't even yet know how many people are already dying due to antimicrobial resistance. By contrast, in the Netherlands they know that there are 2 million hospitalisations per year due to resistance.
"If the Prime Minister knows that there will be 'unbelievably bad consequences' for families, why is his government being so slow about getting a grip on the problem?"
The survey has been sent to 984 veterinary surgeons who graduated from one of the UK’s eight vet schools in 2020 to measure how the pandemic may have affected graduates’ employment prospects, clinical & non-clinical skills, and resilience in the workplace.
The survey has a deadline date of Wednesday 16 December 2020 and all responses to it will remain anonymous while helping to inform future policy on graduate support.
Dr Linda Prescott-Clements, RCVS Director of Education, said: “We know that the coronavirus pandemic has had a disruptive impact on the final stages of education for the 2020 cohort, in terms of clinical placements for extra-mural studies as well as teaching. This survey aims to gauge whether this has, in turn, had a deleterious impact on their confidence with both clinical and non-clinical skills as well as their resilience, for example, in asking for help and support from colleagues, managing their time effectively, and managing complex and stressful situations.
“Employment is another area of concern and in any typical year almost all graduate vets would find work or go on to further study after their veterinary degree had finished. Some anecdotal reports have suggested a perceived or real change to employment prospects this year and so we are hoping to gather some further data to see if there has been a discernible impact on this cohort.
“We are mindful that the pandemic is having a significant impact on all students and we are keen to understand how best we can support them moving forward. I would strongly encourage those graduates who have received the survey, which should only take around 10 minutes to complete, to take part, because the results will help the RCVS and the VSC inform future policies on how we can better support veterinary graduates in 2021 and subsequent years.”
Any graduates who have not received the survey or require further information can contact the RCVS Education Department on education@rcvs.org.uk.